Nuvation Bio, Inc. (NUVB)
5.14
-0.42
(-7.55%)
USD |
NYSE |
Oct 02, 16:00
5.17
+0.03
(+0.58%)
Pre-Market: 20:00
Nuvation Bio Max Drawdown (5Y) : 93.39% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 93.39% |
| August 31, 2026 | 93.39% |
| July 31, 2026 | 93.39% |
| June 30, 2026 | 93.39% |
| May 31, 2026 | 93.39% |
| April 30, 2026 | 93.39% |
| March 31, 2026 | 93.39% |
| February 28, 2026 | 93.39% |
| January 31, 2026 | 93.39% |
| December 31, 2025 | 93.39% |
| November 30, 2025 | 93.39% |
| October 31, 2025 | 93.39% |
| September 30, 2025 | 93.39% |
| August 31, 2025 | 93.39% |
| July 31, 2025 | 93.39% |
| June 30, 2025 | 93.39% |
| May 31, 2025 | 93.39% |
| April 30, 2025 | 93.39% |
| March 31, 2025 | 93.39% |
| February 28, 2025 | 93.39% |
| January 31, 2025 | 93.39% |
| December 31, 2024 | 93.39% |
| November 30, 2024 | 93.39% |
| October 31, 2024 | 93.39% |
| September 30, 2024 | 93.39% |
| Date | Value |
|---|---|
| August 31, 2024 | 93.39% |
| July 31, 2024 | 93.39% |
| June 30, 2024 | 93.39% |
| May 31, 2024 | 93.39% |
| April 30, 2024 | 93.39% |
| March 31, 2024 | 93.39% |
| February 29, 2024 | 93.39% |
| January 31, 2024 | 93.39% |
| December 31, 2023 | 93.39% |
| November 30, 2023 | 93.39% |
| October 31, 2023 | 93.39% |
| September 30, 2023 | 91.35% |
| August 31, 2023 | 89.29% |
| July 31, 2023 | 89.29% |
| June 30, 2023 | 89.29% |
| May 31, 2023 | 89.29% |
| April 30, 2023 | 89.09% |
| March 31, 2023 | 89.02% |
| February 28, 2023 | 88.47% |
| January 31, 2023 | 88.47% |
| December 31, 2022 | 88.47% |
| November 30, 2022 | 87.71% |
| October 31, 2022 | 86.34% |
| September 30, 2022 | 86.34% |
| August 31, 2022 | 84.28% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Bristol Myers Squibb Co. | 47.67% |
| Johnson & Johnson | 18.44% |
| Pfizer Inc. | 58.95% |
| Eli Lilly & Co. | 34.47% |
| Merck & Co., Inc. | 43.45% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -30.75 |
| Beta (5Y) | 1.611 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 71.26% |
| Historical Sharpe Ratio (5Y) | -0.2053 |
| Historical Sortino (5Y) | -0.438 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.87% |